3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Lung Neoplasms
26
Carcinoma, Non-Small-Cell Lung
15
Small Cell Lung Carcinoma
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Melanoma
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pulmonary Disease, Chronic Obstructive
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberculosis
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Thoracic Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdomyosarcoma
1
Precancerous Conditions
1
Pneumonia
1
Pleural Effusion, Malignant
1
Interventions
pembrolizumab
70
Nivolumab
24
Docetaxel
17
Cisplatin
15
Paclitaxel
13
Carboplatin
12
Gemcitabine
8
Cetuximab
8
Ipilimumab
7
durvalumab
6
avelumab
6
atezolizumab
6
Radiotherapy
6
Cyclophosphamide
6
spartalizumab
5
Trastuzumab
5
Taxes
5
Pemetrexed
5
Erlotinib Hydrochloride
5
tremelimumab
4
cemiplimab
4
Specimen Handling
4
Leucovorin
4
Interleukin-2
4
Fluorouracil
4
Capecitabine
4
Biopsy
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
utomilumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
X-Rays
×
Thoracic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled